0000899243-18-022324.txt : 20180814 0000899243-18-022324.hdr.sgml : 20180814 20180814173040 ACCESSION NUMBER: 0000899243-18-022324 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180810 FILED AS OF DATE: 20180814 DATE AS OF CHANGE: 20180814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klump Michael A CENTRAL INDEX KEY: 0001748882 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 181019042 MAIL ADDRESS: STREET 1: ONE BUCKHEAD PLAZA, SUITE 400 STREET 2: 3060 PEACHTREE ROAD NW CITY: ATLANTA STATE: 2Q ZIP: 30305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-08-10 0 0001175680 CytoDyn Inc. CYDY 0001748882 Klump Michael A 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 Common Stock 7034520 I See Footnote Warrant (Right to Buy) 1.35 2016-04-26 2021-04-26 Common Stock 125000 D Warrant (Right to Buy) 1.00 2016-12-12 2021-12-12 Common Stock 1933333 I See Footnote Warrant (Right to Buy) 0.75 2018-02-16 2023-02-16 Common Stock 1000000 I See Footnote Warrant (Right to Buy) 1.00 2016-12-12 2021-12-12 Common Stock 66667 I By The Klump Children's Gift Trust The reported securities of CytoDyn Inc. (the "Company") are held by Argonne Trading, LLC, a Georgia limited liability company ("Argonne Trading"). Argonne Capital Group, LLC, a Georgia limited liability company ("Argonne Capital"), is the sole member of Argonne Trading. Michael A. Klump is Manager, President and Chief Executive Officer of Argonne Capital. Mr. Klump disclaims beneficial ownership of the securities held by Argonne Trading, except to the extent of his pecuniary interest therein. Exhibit List: Exhibit 24 - Power of Attorney /s/ Michael D. Mulholland, as attorney-in-fact 2018-08-14 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

            The undersigned hereby appoints each of Michael D. Mulholland,
Steven M. Skolnick, James O'Grady and Bettina Elstroth, signing singly, as the
undersigned's true and lawful attorney-in-fact to:

            1.	Execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of CytoDyn Inc. (the
"Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder, and any other forms or reports
the undersigned may be required to file in connection with the undersigned's
ownership, acquisition, or disposition of securities of the Company, including
forms required to generate codes for the Securities and Exchange Commission's
electronic filing system; and

            2.	Do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5, or other form or report, and timely file such form or report
with the United States Securities and Exchange Commission and any stock exchange
or similar authority as appropriate.

            The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing necessary or
proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned could do if
personally present, hereby ratifying and confirming all that such attorney-in-
fact shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys- in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, and the Company is not assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

            This Power of Attorney shall remain in full force and effect until
the undersigned is no longer subject to Section 16 of the Securities Exchange
Act of 1934 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.

            IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 14th day of August, 2018.



                                            /s/ Michael A. Klump
                                           -------------------------------------
                                            Signature


                                            Michael A. Klump
                                           -------------------------------------
                                            Print Name